Nouveautés radiologiques dans le dépistage et le diagnostic des erreurs innées du métabolisme Radiological innovations in the diagnosis of the metabolic diseases : spectroscopy and cerebral MRI in creatine deficiencies, polyols anomalies, and metabolites on the pentose pathway-positron emission tomography (PET) after injection of [18F]Fluoro-L-Dopa in congenital hyperinsulinism

Résumé

Les maladies héréditaires du métabolisme ont acquis une place de plus en plus importante dans la pathologie pédiatrique. Leur nombre ne cesse d’augmenter au fur et à mesure de la progression des connaissances en biologie cellulaire et des progrès techniques d’investigation. Nous traiterons ici de trois maladies métaboliques que l’imagerie fonctionnelle et la spectroscopie IRM ont permis d’identifier. Il s’agit des déficits en créatine traitables par l’administration de créatine et les défauts du métabolisme des polyols qui ouvrent le champ sur de nouveaux déficits enzymatiques responsables de présentations cliniques très variées. Nous aborderons également les hyperinsulinismes du jeune enfant dont le diagnostic et la prise en charge ont été récemment transformées par l’utilisation de la [18F]-fluoro-L-DOPA en tomographie par émission de positons.

Summary

New metabolic diseases are regularly identified by a genetic or biochemical approach. Indeed, the metabolic diseases result from an enzymatic block with accumulation of a metabolite upstream to the block and deficit of a metabolite downstream. The characterization of these abnormal metabolites by MRI spectroscopy permitted to identify the deficient enzyme in two new groups of diseases, creatine deficiencies and polyol anomalies. Creatine deficiency is implicated in unspecific mental retardation. A low peak of creatine at MRI spectroscopy is evocating of creatine deficiency which is treatable by creatine administration. Deficiency of synthesis of polyols, metabolites on the pentose pathway, represent new described metabolic diseases with variable symptoms including a neurological distress, liver disease, splenomegaly, cutis laxa and renal insufficiency. The deficit of ribose-5-phosphate isomerase, one of the enzymes whose diagnosis is evoked in front of the accumulation of ribitol, arabitol and xylitol leads to a leucodystrophy in adults. This new deficit was highlighted by the identification of an abnormal peak in cerebral MRI-spectroscopy corresponding to the abnormal accumulation of polyols in brain. Congenital hyperinsulinism (HI) is characterized by profound hypoglycaemia related to inappropriate insulin secretion. Focal and diffuse forms of hyperinsulinism share a similar clinical presentation but their treatment is dramatically different. Until recently, preoperative differential diagnosis was based on pancreatic venous sampling, an invasive and technically demanding technique. Positron emission tomography (PET) after injection of [18F]Fluoro-L-DOPA has been evaluated for the preoperative differentiation between focal and diffuse HI, by imaging uptake of radiotracer and the conversion of [18F]Fluoro-L-DOPA into dopamine by DOPA decarboxylase. PET with [18F]Fluoro-L-DOPA has been validated as a reliable test to differentiate diffuse and focal HI and is now a major differential diagnosis tool in infantile hyperinsulinemic hypoglycaemia.